Adaptation of an R5 Simian-Human Immunodeficiency Virus Encoding an HIV Clade A Envelope with or without Ablation of Adaptive Host Immunity: Differential Selection of Viral Mutants.


Journal

Journal of virology
ISSN: 1098-5514
Titre abrégé: J Virol
Pays: United States
ID NLM: 0113724

Informations de publication

Date de publication:
01 05 2019
Historique:
received: 19 12 2018
accepted: 05 02 2019
pubmed: 15 2 2019
medline: 29 1 2020
entrez: 15 2 2019
Statut: epublish

Résumé

Simian-human immunodeficiency virus (SHIV) infection in rhesus macaques (RMs) resembles human immunodeficiency virus type 1 (HIV-1) infection in humans and serves as a tool to evaluate candidate AIDS vaccines. HIV-1 clade A (HIV-A) predominates in parts of Africa. We constructed an R5 clade A SHIV (SHIV-A; strain SHIV-KNH1144) carrying

Identifiants

pubmed: 30760566
pii: JVI.02267-18
doi: 10.1128/JVI.02267-18
pmc: PMC6475780
pii:
doi:

Substances chimiques

env Gene Products, Human Immunodeficiency Virus 0

Types de publication

Journal Article Research Support, N.I.H., Extramural Research Support, Non-U.S. Gov't

Langues

eng

Sous-ensembles de citation

IM

Subventions

Organisme : NIAID NIH HHS
ID : R01 AI118586
Pays : United States
Organisme : NIH HHS
ID : P51 OD011132
Pays : United States
Organisme : NIAID NIH HHS
ID : P01 AI048240
Pays : United States
Organisme : NIAID NIH HHS
ID : R01 AI100703
Pays : United States
Organisme : NIAID NIH HHS
ID : R37 AI034266
Pays : United States
Organisme : NIH HHS
ID : P51 OD011133
Pays : United States

Informations de copyright

Copyright © 2019 American Society for Microbiology.

Références

Bioinformatics. 2009 Jul 15;25(14):1754-60
pubmed: 19451168
AIDS Res Hum Retroviruses. 1992 Apr;8(4):451-9
pubmed: 1376134
AIDS. 2013 Jun 1;27(9):F13-20
pubmed: 23775002
Cell Host Microbe. 2014 Sep 10;16(3):412-8
pubmed: 25211081
Virology. 2002 Jul 5;298(2):189-99
pubmed: 12127782
AIDS. 2011 Mar 13;25(5):679-89
pubmed: 21297424
J Gen Virol. 2013 Jan;94(Pt 1):1-19
pubmed: 23079381
PLoS One. 2012;7(1):e30963
pubmed: 22303476
AIDS Res Hum Retroviruses. 2002 Aug 10;18(12):891-5
pubmed: 12201913
Cell Host Microbe. 2008 Apr 17;3(4):245-52
pubmed: 18342597
J Virol. 2013 May;87(10):5424-36
pubmed: 23468483
Virology. 2008 Jun 5;375(2):529-38
pubmed: 18433824
J Infect Dis. 2010 Apr 15;201(8):1155-63
pubmed: 20214475
AIDS. 2003 Sep 5;17(13):1871-9
pubmed: 12960819
J Virol. 1992 Feb;66(2):750-6
pubmed: 1370557
Retrovirology. 2015 Aug 25;12:75
pubmed: 26303815
J Virol. 2015 Jan 15;89(2):894-907
pubmed: 25378497
J Virol. 1997 Jun;71(6):4218-25
pubmed: 9151808
Curr Opin Virol. 2011 Oct;1(4):246-53
pubmed: 22081778
J Virol. 2009 Feb;83(3):1422-32
pubmed: 19019970
AIDS Res Hum Retroviruses. 2005 Dec;21(12):1060-5
pubmed: 16379611
J Immunol. 1995 Jul 1;155(1):473-88
pubmed: 7602119
J Virol. 2011 May;85(9):4409-20
pubmed: 21325401
Nature. 2008 Jan 24;451(7177):425-30
pubmed: 18200009
J Virol. 1995 Jan;69(1):263-71
pubmed: 7983718
AIDS. 2002 Sep 6;16(13):1809-20
pubmed: 12218394
J Virol. 2018 Jun 29;92(14):
pubmed: 29743361
Retrovirology. 2015 Jun 16;12:49
pubmed: 26076651
Proc Natl Acad Sci U S A. 2012 Nov 13;109(46):18921-5
pubmed: 23100539
PLoS One. 2011;6(7):e22010
pubmed: 21799765
Virology. 1997 Nov 24;238(2):305-15
pubmed: 9400603
J Virol. 2012 Dec;86(23):12472-83
pubmed: 22973036
J Virol. 2001 Apr;75(8):4019-22
pubmed: 11264395
Proc Natl Acad Sci U S A. 2016 Jun 14;113(24):E3413-22
pubmed: 27247400
J Infect Dis. 2015 Oct 1;212 Suppl 2:S295-304
pubmed: 25920319
Bioinformatics. 2009 Sep 1;25(17):2283-5
pubmed: 19542151
AIDS. 2009 Nov 27;23(18):2479-84
pubmed: 19841572
J Virol. 2000 Aug;74(16):7400-10
pubmed: 10906193
J Virol. 1993 Mar;67(3):1707-11
pubmed: 8437240
PLoS Pathog. 2013;9(7):e1003487
pubmed: 23853598
Genome Res. 2012 Mar;22(3):568-76
pubmed: 22300766
J Virol. 2002 Jun;76(11):5803-6
pubmed: 11992009
Science. 2014 Jun 20;344(6190):1401-5
pubmed: 24948736
AIDS Res Hum Retroviruses. 1998 May 20;14(8):669-76
pubmed: 9618078
AIDS. 2006 Nov 14;20(17):2135-40
pubmed: 17086052
Bioinformatics. 2010 Mar 15;26(6):841-2
pubmed: 20110278
J Virol. 2001 Jan;75(2):738-49
pubmed: 11134287
J Virol. 2014 Nov;88(21):12623-43
pubmed: 25142591
J Virol. 2006 Sep;80(17):8729-38
pubmed: 16912320
Virology. 2011 Sep 30;418(2):123-32
pubmed: 21851958
J Virol. 2005 Dec;79(23):14887-98
pubmed: 16282488

Auteurs

Mingkui Zhou (M)

Texas Biomedical Research Institute, San Antonio, Texas, USA.
Dana-Farber Cancer Institute, Boston, Massachusetts, USA.
Department of Medicine, Harvard Medical School, Boston, Massachusetts, USA.

Michael Humbert (M)

Dana-Farber Cancer Institute, Boston, Massachusetts, USA.
Department of Medicine, Harvard Medical School, Boston, Massachusetts, USA.

Muhammad M Mukhtar (MM)

Texas Biomedical Research Institute, San Antonio, Texas, USA.
Dana-Farber Cancer Institute, Boston, Massachusetts, USA.
Department of Medicine, Harvard Medical School, Boston, Massachusetts, USA.

Hanna B Scinto (HB)

Texas Biomedical Research Institute, San Antonio, Texas, USA.
Department of Microbiology, Immunology & Molecular Genetics, University of Texas Health Science Center at San Antonio, San Antonio, Texas, USA.

Hemant K Vyas (HK)

Texas Biomedical Research Institute, San Antonio, Texas, USA.
Dana-Farber Cancer Institute, Boston, Massachusetts, USA.
Department of Medicine, Harvard Medical School, Boston, Massachusetts, USA.

Samir K Lakhashe (SK)

Texas Biomedical Research Institute, San Antonio, Texas, USA.
Dana-Farber Cancer Institute, Boston, Massachusetts, USA.
Department of Medicine, Harvard Medical School, Boston, Massachusetts, USA.

Siddappa N Byrareddy (SN)

Dana-Farber Cancer Institute, Boston, Massachusetts, USA.
Department of Medicine, Harvard Medical School, Boston, Massachusetts, USA.

Gregor Maurer (G)

Texas Biomedical Research Institute, San Antonio, Texas, USA.
VetCore, Facility for Research, University of Veterinary Medicine Vienna, Vienna, Austria.

Swati Thorat (S)

Dana-Farber Cancer Institute, Boston, Massachusetts, USA.
Department of Medicine, Harvard Medical School, Boston, Massachusetts, USA.

Joshua Owuor (J)

Texas Biomedical Research Institute, San Antonio, Texas, USA.

Zhao Lai (Z)

Greehey Children's Cancer Research Institute, University of Texas Health Science Center at San Antonio, San Antonio, Texas, USA.

Yidong Chen (Y)

Greehey Children's Cancer Research Institute, University of Texas Health Science Center at San Antonio, San Antonio, Texas, USA.
Department of Epidemiology and Biostatistics, University of Texas Health Science Center at San Antonio, San Antonio, Texas, USA.

Anthony Griffiths (A)

Texas Biomedical Research Institute, San Antonio, Texas, USA.

Agnès-Laurence Chenine (AL)

Dana-Farber Cancer Institute, Boston, Massachusetts, USA.
Department of Medicine, Harvard Medical School, Boston, Massachusetts, USA.
Henry M. Jackson Foundation, Bethesda, Maryland, USA.
Military HIV Research Program, Silver Spring, Maryland, USA.

Sanjeev Gumber (S)

Yerkes National Primate Research Center, Emory University, Atlanta, Georgia, USA.
Department of Pathology and Laboratory Medicine, Emory University, Atlanta, Georgia, USA.

François Villinger (F)

Yerkes National Primate Research Center, Emory University, Atlanta, Georgia, USA.
Department of Pathology and Laboratory Medicine, Emory University, Atlanta, Georgia, USA.

David Montefiori (D)

Department of Surgery, Duke University School of Medicine, Durham, North Carolina, USA.

Ruth M Ruprecht (RM)

Texas Biomedical Research Institute, San Antonio, Texas, USA rruprecht@txbiomed.org.
Southwest National Primate Research Center, San Antonio, Texas, USA.
Dana-Farber Cancer Institute, Boston, Massachusetts, USA.
Department of Medicine, Harvard Medical School, Boston, Massachusetts, USA.
Department of Microbiology, Immunology & Molecular Genetics, University of Texas Health Science Center at San Antonio, San Antonio, Texas, USA.

Articles similaires

[Redispensing of expensive oral anticancer medicines: a practical application].

Lisanne N van Merendonk, Kübra Akgöl, Bastiaan Nuijen
1.00
Humans Antineoplastic Agents Administration, Oral Drug Costs Counterfeit Drugs

Smoking Cessation and Incident Cardiovascular Disease.

Jun Hwan Cho, Seung Yong Shin, Hoseob Kim et al.
1.00
Humans Male Smoking Cessation Cardiovascular Diseases Female
Humans United States Aged Cross-Sectional Studies Medicare Part C
1.00
Humans Yoga Low Back Pain Female Male

Classifications MeSH